Savant Capital LLC held its stake in shares of Aetna Inc. (NYSE:AET) during the second quarter, Holdings Channel reports. The institutional investor owned 2,821 shares of the company’s stock at the end of the second quarter. Savant Capital LLC’s holdings in Aetna were worth $345,000 at the end of the most recent reporting period.
Other large investors also recently made changes to their positions in the company. Teachers Advisors Inc. raised its stake in shares of Aetna by 3.5% in the first quarter. Teachers Advisors Inc. now owns 396,540 shares of the company’s stock worth $44,551,000 after buying an additional 13,543 shares during the last quarter. Franklin Resources Inc. increased its position in Aetna by 21.9% in the first quarter. Franklin Resources Inc. now owns 950,209 shares of the company’s stock worth $106,756,000 after buying an additional 170,457 shares during the period. NN Investment Partners Holdings N.V. acquired a new position in Aetna during the first quarter worth approximately $17,071,000. Bessemer Group Inc. increased its position in Aetna by 1.1% in the first quarter. Bessemer Group Inc. now owns 937,441 shares of the company’s stock worth $105,321,000 after buying an additional 9,898 shares during the period. Finally, Advisor Partners LLC increased its position in Aetna by 22.2% in the first quarter. Advisor Partners LLC now owns 6,897 shares of the company’s stock worth $775,000 after buying an additional 1,251 shares during the period. Institutional investors own 91.95% of the company’s stock.
Shares of Aetna Inc. (NYSE:AET) traded down 0.86% during mid-day trading on Thursday, reaching $113.99. 1,469,529 shares of the company’s stock traded hands. The firm has a market cap of $39.99 billion, a price-to-earnings ratio of 16.70 and a beta of 0.54. The firm’s 50-day moving average is $116.49 and its 200 day moving average is $115.79. Aetna Inc. has a one year low of $92.42 and a one year high of $123.57.
Aetna (NYSE:AET) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported $2.21 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.12 by $0.09. The business had revenue of $15.95 billion for the quarter, compared to analysts’ expectations of $15.69 billion. Aetna had a net margin of 3.89% and a return on equity of 16.44%. The business’s quarterly revenue was up 4.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.05 earnings per share. Analysts predict that Aetna Inc. will post $8.05 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Thursday, October 13th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Tuesday, October 11th. This represents a $1.00 annualized dividend and a dividend yield of 0.88%. Aetna’s dividend payout ratio is presently 14.73%.
A number of research firms have commented on AET. Credit Suisse Group AG reissued a “hold” rating and set a $120.00 target price on shares of Aetna in a research report on Wednesday, August 3rd. Leerink Swann reissued a “buy” rating and set a $135.00 target price on shares of Aetna in a research report on Thursday, August 4th. Morgan Stanley reissued a “buy” rating on shares of Aetna in a research report on Tuesday, June 14th. FBR & Co reissued a “hold” rating and set a $135.00 target price on shares of Aetna in a research report on Thursday, August 4th. Finally, Zacks Investment Research raised shares of Aetna from a “hold” rating to a “buy” rating and set a $133.00 target price on the stock in a research report on Tuesday, July 19th. Six investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Aetna presently has an average rating of “Buy” and a consensus price target of $132.43.
In related news, Director Jeffrey E. Garten sold 7,100 shares of the firm’s stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $116.51, for a total value of $827,221.00. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Shawn M. Guertin sold 45,328 shares of the firm’s stock in a transaction that occurred on Tuesday, August 23rd. The shares were sold at an average price of $120.21, for a total transaction of $5,448,878.88. Following the completion of the sale, the insider now directly owns 44,883 shares in the company, valued at approximately $5,395,385.43. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by corporate insiders.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.